Villejuif Cedex

• A study to Evaluate Efficacy and Safety of Giredestrant Compared with Fulvestrant (plus a CDK4/6 inhibitor), in Participants with ER+ HER2-N … Recruiting
  2022-502980-39-00 5 2024-01-25 Estrogen receptor (ER)-positive, HER2-negative advanced breast cancer
• Study aiming to assess the clinical impact of dostarlimab on occurrence of second primary cancer in patients with cured primary cancer Recruiting
  2022-501316-34-00 4 2023-11-27 Patient cured from a primary cancer and at risk of 2nd cancer
• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnorma … Recruiting
  2022-501943-34-00 5 2023-06-27 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
• NAlmefene versus placebo in addition to treatment as usual on craving in Behavioural Addictions (NABAb) Recruiting
  2022-500085-96-00 5 2023-03-31 Patients with gambling disorder or sexual addiction or food addiction
• Randomized prospective trial evaluating the efficacy of the antiCD38 monoclonal antibody isatuximab in the treatment of PCRA by major ABO mi … Recruiting
  2024-514351-14-00 4 2023-02-20 Pure cell red aplasia by major ABO mismatch after allogeneic hematopoi
• Phase 1/1b study to assess the drug OBT076 in patients with recurrent and/or metastatic CD205-positive solid tumors Recruiting
  2024-511884-27-00 3 2022-11-09 CD205+ve recurrent and/or metastatic tumor types including but not lim
• TERTIO : Evaluation de l’intérêt de combiner un vaccin inducteur de CD4-Th1 dérivé de la télomérase avec un traitement par atezolizumab et b … Recruiting
  2022-500643-20-00 4 2022-09-27 Patients with locally advanced, metastatic or unresectable hepatocellu
• A study to evaluate efficacy and safety of an investigational drug named volixibat in patients with itching caused by primary biliary cholan … Recruiting
  2023-504660-41-00 4 2022-07-11 Cholestatic Pruritus in Patients with Primary Biliary Cholangitis (PBC
• Study evaluating the clinical impact of HDM201 + Pazopanib in patients with P53 wild-type advanced/ metastatic soft tissue sarcomas. Recruiting
  2024-510706-86-00 9 2022-05-16 Advanced/ metastatic soft tissue sarcomas
• PEMBROCABOSARC : Combination of pembrolizumab and cabozantinib in patients with advanced sarcomas Recruiting
  2023-509496-16-00 4 2022-04-21 Advanced /metastatic sarcomas: undifferentiated pleomorphic sarcoma, o
• Multicentric non-randomized phase II of pembrolizumab in combination with etoposide-cisplatin-based chemotherapy in first-line small cell ov … Recruiting
  2024-515310-40-01 4 2021-08-04 Patients with a confirmed diagnosis of ovarian small cell carcinoma.
• Beamion LUNG-1: A study to test different doses of zongertinib in people with different types of advanced cancer (solid tumours with changes … Recruiting
  2024-511246-39-00 1 2021-07-27 Solid tumours with HER2 aberrations
• The ABC-HCC Trial: A Phase IIIb, randomized, multicenter, open-label trial of Atezolizumab plus Bevacizumab versus transarterial Chemoemboli … Recruiting
  2024-512953-26-00 5 2021-07-06 intermediate-stage hepatocellular carcinoma
• Roll Over Study for Patients Who Have Completed a Previous Oncology Study with Olaparib Recruiting
  2024-512982-15-00 5 2021-06-28 BRCA Mutated Ovarian Cancer Patients, Epithelian ovarian cancer, Metas
• Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cance … Recruiting
  2024-515344-23-00 4 2021-06-17 local advenced pancreatic adenocarcinoma
• Study evaluating near-infrared imaging coupled with indocyanine green for intraoperative monitoring of resection margins in ENT surgery Recruiting
  2022-502737-26-00 4 2020-12-15 epidermoid carcinoma
• Study of REGN4018 (Ubamatamab) Administered Alone or in Combination with Cemiplimab in Adult Patients with Recurrent Ovarian Cancer or Other … Recruiting
  2024-510783-23-00 7 2020-10-29 Fallopian Tube Cancer
• FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting
  2024-510579-40-00 9 2020-10-07 Rhabdoyosarcoma
• Multicentric phase III trial comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine ad … Recruiting
  2024-514603-34-00 5 2020-03-02 intermediate-risk differentiated thyroid cancer patients
• Extension Study for Participants in Studies That Include Pembrolizumab Recruiting
  2022-501254-10-00 5 2018-08-24 Advanced tumors
• CAR T-cell therapy long term follow-up Recruiting
  2023-508128-37-00 5 2017-07-19 All patients who have been treated with Novartis or Penn CAR T-cell th
• rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma Recruiting
  2024-516078-31-00 10 2015-05-05 Recurrent and Primary Refractory Ewing Sarcoma
• Phase 3 study of RMC-6236 in patients with previously treated metastatic PDAC Ended recruitment
  2024-516063-89-00 5 2025-04-10 Metastatic Pancreatic Ductal Adenocarcinoma
• PRODIGE 49 - OSCAR: Systemic oxaliplatin or in intra-arterial chemotherapy combined with LV5FU2 ± Irinotecan, and targeted therapy, in first … Ended recruitment
  2024-518553-41-00 5 2024-11-08 colon cancer and rectal with liver metastasis

Showing 49–72 of 108 trials